Article Text

Download PDFPDF
Vasculitis, antiphospholipid antibodies, and renal artery stenosis
  1. S N Paul1,
  2. S R Sangle1,
  3. A N Bennett1,
  4. M El-Hachmi1,
  5. R Hangartner2,
  6. G R Hughes1,
  7. D P D’Cruz1
  1. 1Louise Coote Lupus Unit, St Thomas’ Hospital, London SE1 7EH, UK
  2. 2Department of Histopathology, St Thomas’ Hospital, London SE1 7EH, UK
  1. Correspondence to:
    Dr D P D’Cruz
    david.d'cruzkcl.ac.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Antiphospholipid antibodies (aPL) are considered to be non-pathogenic in patients with vasculitis. We present five patients with primary vasculitis who had aPL and renal artery stenosis (RAS); one of these patients had coexistent renal pathology due to primary vasculitis, and micro- and macropathology due to renal manifestations of the antiphospholipid syndrome.

A 44 year old white smoker presented with sinusitis, haemoptysis, and arthritis. She was normotensive. A chest x ray demonstrated cavitating lesions. She was cANCA positive and fulfilled the American College of Rheumatology criteria for Wegener’s granulomatosis (WG).1 aPL were detected, although she lacked a history of thromboses or pregnancy morbidity. Her serum C reactive protein level was raised at 100 mg/l. Clinical and serological remission was achieved with intravenous cyclophosphamide followed by maintenance methotrexate and corticosteroid treatment.

After discontinuing corticosteroids, she became hypertensive and her previously normal renal function deteriorated. Her …

View Full Text